Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas

Cellular Oncology

Volumn 34, Issue 5, 2011, Pages 419-434

  Kretschmer, Celine ^a   Conradi, Anne ^b   Kemmner, Wolfgang ^c   Sterner Kock, Anja ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c ECRC   (Germany)

Author keywords

Carcinogenesis; DCIS; LTBP4; Mammary carcinoma; TGF ; Tumour suppressor gene

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; CKTSF1B1 PROTEIN, MOUSE; GREM1 PROTEIN, HUMAN; ISOPROTEIN; LTBP4 PROTEIN, HUMAN; SIGNAL PEPTIDE; SMAD PROTEIN; TUMOR PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CANCER INVASION; CELL STRAIN MCF 7; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION PROFILING; GREMLIN GENE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN1 GENE; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN3 GENE; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN4 GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN MICROARRAY; ANIMAL; BREAST TUMOR; EPITHELIUM CELL; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; BONE MORPHOGENETIC PROTEIN 4; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL LINE, TUMOR; DOWN-REGULATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LATENT TGF-BETA BINDING PROTEINS; MAMMARY NEOPLASMS, ANIMAL; MICE; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; SMAD PROTEINS;

EID: 84860590379     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-011-0023-y     Document Type: Article

References (62)

1. C.C. Bascom, N.J. Sipes, R.J. Coffey, H.L. Moses, Regulation of epithelial cell proliferation by transforming growth factors. J. Cell. Biochem. 39, 25-32 (1989)
2. C.C. Bascom, J.R. Wolfshohl, R.J. Coffey Jr., L. Madisen, N.R. Webb, A.R. Purchio, R. Derynck, H.L. Moses, Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2.Mol. Cell. Biol. 9, 5508-5515 (1989)
3. N.A. Bhowmick, A. Chytil, D. Plieth, A.E. Gorska, N. Dumont, S. Shappell, M.K. Washington, E.G. Neilson, H.L. Moses, TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303, 848-851 (2004)
4. D. Bobinac, I. Maric, S. Zoricic, J. Spanjol, G. Dordevic, E. Mustac, Z. Fuckar, Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer. Croat. Med. J. 46, 389-396 (2005)
5. J.T. Buijs, N.V. Henriquez, P.G. van Overveld, G. van der Horst, I. Que, R. Schwaninger, C. Rentsch, D.P. Ten, A.M. Cleton-Jansen, K. Driouch, R. Lidereau, R. Bachelier, S. Vukicevic, P. Clezardin, S.E. Papapoulos,M.G. Cecchini, C.W. Lowik, G. van der Pluijm, Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Cancer Res. 67, 8742-8751 (2007)
6. A. Chaudhry, K. Oberg, A. Gobl, C.H. Heldin, K. Funa, Expression of transforming growth factors beta 1, beta 2, beta 3 in neuroendocrine tumors of the digestive system. Anticancer Res. 14, 2085-2091 (1994)
7. S.L. Dallas, S. Park-Snyder, K. Miyazono, D. Twardzik, G.R. Mundy, L.F. Bonewald, Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblastlike cell lines. Production of a latent complex lacking the latent TGF beta-binding protein. J. Biol. Chem. 269, 6815-6821 (1994)
8. S. Eklov, K. Funa, H. Nordgren, A. Olofsson, T. Kanzaki, K. Miyazono, S. Nilsson, Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue. Cancer Res. 53, 3193-3197 (1993)
9. A.E. Elkak, R.F. Newbold, V. Thomas, K. Mokbel, Is telomerase reactivation associated with the down-regulation of TGF beta receptor-II expression in human breast cancer? Cancer Cell Int 3, 9 (2003)
10. K. Eppert, S.W. Scherer, H. Ozcelik, R. Pirone, P. Hoodless, H. Kim, L.C. Tsui, B. Bapat, S. Gallinger, I.L. Andrulis, G.H. Thomsen, J.L. Wrana, L.Attisano,MADR2maps to 18q21 and encodes a TGFbetaregulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86, 543-552 (1996)
11. K.C. Flanders, N.L. Thompson, D.S. Cissel, E. Van Obberghen-Schilling, C.C. Baker, M.E. Kass, L.R. Ellingsworth, A.B. Roberts, M.B. Sporn, Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes. J. Cell Biol. 108, 653-660 (1989)
12. R.S. Frey, K.M. Mulder, TGFbeta regulation of mitogen-activated protein kinases in human breast cancer cells. Cancer Lett. 117, 41-50 (1997)
13. M.A. Gibson, G. Hatzinikolas, E.C. Davis, E. Baker, G.R. Sutherland, R.P. Mecham, Bovine latent transforming growth factor beta 1-binding protein 2: molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils. Mol. Cell. Biol. 15, 6932-6942 (1995)
14. W.M. Grady, L.L. Myeroff, S.E. Swinler, A. Rajput, S. Thiagalingam, J.D. Lutterbaugh,A. Neumann, M.G. Brattain, J. Chang, S.J. Kim,K. W. Kinzler, B. Vogelstein, J.K. Willson, S. Markowitz, Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res. 59, 320-324 (1999)
15. R. Henriksen, A. Gobl, E. Wilander, K. Oberg, K. Miyazono, K. Funa, Expression and prognostic significance of TGF-beta isotypes, latent TGF-beta 1 binding protein. TGF-beta type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms. Lab Invest 73, 213-220 (1995)
16. M. Hyytiainen, J. Taipale, C.H. Heldin, J. Keski-Oja, Recombinant latent transforming growth factor beta-binding protein 2 assembles to fibroblast extracellular matrix and is susceptible to proteolytic processing and release. J. Biol. Chem. 273, 20669-20676 (1998)
17. J.C. Jennings, S. Mohan, T.A. Linkhart, R. Widstrom, D.J. Baylink, Comparison of the Biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells. J. Cell. Physiol. 137, 167-172 (1988)
18. J.S. Jeruss, C.D. Sturgis, A.W. Rademaker, T.K. Woodruff, Downregulation of activin, activin receptors, and Smads in high-grade breast cancer. Cancer Res. 63, 3783-3790 (2003)
19. R.L. Jirtle, J.D. Haag, E.A. Ariazi, M.N. Gould, Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor beta 1 levels during monoterpene-induced regression of mammary tumors. Cancer Res. 53, 3849-3852 (1993)
20. V.G. Kaklamani, L. Baddi, J. Liu, D. Rosman, S. Phukan, C. Bradley, C. Hegarty, B. McDaniel, A. Rademaker, C. Oddoux, H. Ostrer, L.S. Michel, H. Huang, Y. Chen, H. Ahsan, K. Offit, B. Pasche, Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk. Cancer Res. 65, 3454-3461 (2005)
21. T. Kanzaki, A. Olofsson, A. Moren, C. Wernstedt, U. Hellman, K. Miyazono, L. Claesson-Welsh, C.H. Heldin, TGF-beta 1 binding protein: a component of the large latent complex of TGF-beta 1 with multiple repeat sequences. Cell 61, 1051-1061 (1990)
22. B.G. Kim, C. Li, W. Qiao, M. Mamura, B. Kasprzak, M. Anver, L. Wolfraim, S. Hong, E. Mushinski, M. Potter, S.J. Kim, X.Y. Fu, C. Deng, J.J. Letterio, Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441, 1015-1019 (2006)
23. E.S. Kim, M.S. Kim, A. Moon, Transforming growth factor (TGF)-beta in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells. Cytokine 29, 84-91 (2005)
24. D.M. Kingsley, The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8, 133-146 (1994)
25. K. Koli, J. Saharinen, M. Hyytiainen, C. Penttinen, J. Keski-Oja, Latency, activation, and binding proteins of TGF-beta. Microsc. Res. Tech. 52, 354-362 (2001)
26. K. Koli, J. Saharinen, M. Karkkainen, J. Keski-Oja, Novel non-TGF-beta-binding splice variant of LTBP-4 in human cells and tissues provides means to decrease TGF-beta deposition. J. Cell Sci. 114, 2869-2878 (2001)
27. K. Koli, F. Wempe, A. Sterner-Kock, A. Kantola, M. Komor, W. K. Hofmann, M. H. von and J. Keski-Oja, Disruption of LTBP-4 function reduces TGF-beta activation and enhances BMP-4 signaling in the lung. J. Cell Biol. 167, 123-133 (2004)
28. C. Koski, J. Saharinen, J. Keski-Oja, Independent promoters regulate the expression of two amino terminally distinct forms of latent transforming growth factor-beta binding protein-1 (LTBP-1) in a cell type-specific manner. J. Biol. Chem. 274, 32619-32630 (1999)
29. H.M. Kuerer, C.T. Albarracin, W.T. Yang, R.D. Cardiff, A.M. Brewster, W.F. Symmans, N.M. Hylton, L.P. Middleton, S. Krishnamurthy, G.H. Perkins, G. Babiera, M.E. Edgerton, B.J. Czerniecki, B.K. Arun, G.N. Hortobagyi, Ductal carcinoma in situ: state of the science and roadmap to advance the field. J. Clin. Oncol. 27, 279-288 (2009)
30. Q. Li, L. Wu, D.K. Oelschlager, M. Wan, C.R. Stockard, W.E. Grizzle, N. Wang, H. Chen, Y. Sun, X. Cao, Smad4 inhibits tumor growth by inducing apoptosis in estrogen receptor-alpha-positive breast cancer cells. J. Biol. Chem. 280, 27022-27028 (2005)
31. X. Liu, J. Yue, R.S. Frey, Q. Zhu, K.M. Mulder, Transforming growth factor beta signaling through Smad1 in human breast cancer cells. Cancer Res. 58, 4752-4757 (1998)
32. K.J. Livak, T.D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408 (2001)
33. X.J. Ma, R. Salunga, J.T. Tuggle, J. Gaudet, E. Enright, P. McQuary, T. Payette, M. Pistone, K. Stecker, B.M. Zhang, Y.X. Zhou, H. Varnholt, B. Smith, M. Gadd, E. Chatfield, J. Kessler, T. M. Baer, M.G. Erlander, D.C. Sgroi, Gene expression profiles of human breast cancer progression. Proc. Natl Acad. Sci. U.S.A. 100, 5974-5979 (2003)
34. S. Mauel, B. Kruse, B. Etschmann, A.G. von der Schulenburg, M. Schaerig, K. Stovesand, B. Wilcken, A. Sterner-Kock, Latent transforming growth factor binding protein 4 (LTBP-4) is downregulated in human mammary adenocarcinomas in vitro and in vivo. APMIS 115, 687-700 (2007)
35. R.McMahon, M. Murphy, M. Clarkson,M. Taal, H.S. Mackenzie,C. Godson, F. Martin, H.R. Brady, IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta1. J. Biol. Chem. 275, 9901-9904 (2000)
36. K. Miyazono, A. Olofsson, P. Colosetti, C.H. Heldin, A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. EMBO J. 10, 1091-1101 (1991)
37. K. Miyazono, J. Thyberg, C.H. Heldin, Retention of the transforming growth factor-beta 1 precursor in the Golgi complex in a latent endoglycosidase H-sensitive form. J. Biol. Chem. 267, 5668-5675 (1992)
38. T. Mizoi, H. Ohtani, K. Miyazono, M. Miyazawa, S. Matsuno, H. Nagura, Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells. Cancer Res. 53, 183-190 (1993)
39. A. Moren, A. Olofsson, G. Stenman, P. Sahlin, T. Kanzaki, L. Claesson-Welsh, D.P. Ten, K. Miyazono, C.H. Heldin, Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein. J. Biol. Chem. 269, 32469-32478 (1994)
40. H. Namkoong, S.M. Shin, H.K. Kim, S.A. Ha, G.W. Cho, S.Y. Hur, T.E. Kim, J.W. Kim, The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein. BMC Cancer 6, 74 (2006)
41. T. Nishidate, T. Katagiri,M.L. Lin, Y.Mano, Y. Miki, F. Kasumi, M. Yoshimoto, T. Tsunoda, K. Hirata, Y. Nakamura, Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis. Int. J. Oncol. 25, 797-819 (2004)
42. R. Oklu, R. Hesketh, The latent transforming growth factor beta binding protein (LTBP) family. Biochem. J. 352(Pt 3), 601-610 (2000)
43. C. Penttinen, J. Saharinen, K. Weikkolainen, M. Hyytiainen, J. Keski-Oja, Secretion of human latent TGF-beta-binding protein-3 (LTBP-3) is dependent on co-expression of TGF-beta. J. Cell Sci. 115, 3457-3468 (2002)
44. B. Romeis, Mikroskopische Technik (Urban & Fischer, Mchn, 2001)
45. S. Roth-Eichhorn, B. Heitmann, P. Flemming, S. Kubicka, C. Trautwein, Evidence for the decreased expression of the latent TGF-beta binding protein and its splice form in human liver tumours. Scand. J. Gastroenterol. 36, 1204-1210 (2001)
46. G.H. Sakorafas, The origins of radical mastectomy. AORN J. 88, 605-608 (2008)
47. B. Schmierer, C.S. Hill, Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor beta-dependent nuclear accumulation of Smads. Mol. Cell. Biol. 25, 9845-9858 (2005)
48. C.S. Schuetz, M. Bonin, S.E. Clare, K. Nieselt, K. Sotlar, M. Walter, T. Fehm, E. Solomayer, O. Riess, D. Wallwiener, R. Kurek, H.J. Neubauer, Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res. 66, 5278-5286 (2006)
49. C. Schulze-Garg, J. Lohler, A. Gocht, W. Deppert, A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland. Oncogene 19, 1028-1037 (2000)
50. S. Sinha, C. Nevett, C.A. Shuttleworth, C.M. Kielty, Cellular and extracellular biology of the latent transforming growth factor-beta binding proteins. Matrix Biol. 17, 529-545 (1998)
51. A. Sterner-Kock, I.S. Thorey, K. Koli, F. Wempe, J. Otte, T. Bangsow, K. Kuhlmeier, T. Kirchner, S. Jin, J. Keski-Oja, H. von Melchner, Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes Dev. 16, 2264-2273 (2002)
52. M.A. Stull, A.M. Rowzee, A.V. Loladze, T.L. Wood, Growth factor regulation of cell cycle progression in mammary epithelial cells. J. Mammary Gland Biol. Neoplasia 9, 15-26 (2004)
53. J. Taipale, K. Miyazono, C.H. Heldin, J. Keski-Oja, Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J. Cell Biol. 124, 171-181 (1994)
54. J. Taipale, J. Saharinen, K. Hedman, J. Keski-Oja, Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. J. Histochem. Cytochem. 44, 875-889 (1996)
55. S.W. Tobin, M.K. Brown, K. Douville, D.C. Payne, A. Eastman, B.A. Arrick, Inhibition of transforming growth factor beta signaling in MCF-7 cells results in resistance to tumor necrosis factor alpha: a role for Bcl-2. Cell Growth Differ. 12, 109-117 (2001)
56. N. Todorovic-Rakovic, TGF-beta 1 could be a missing link in the interplay between ER and HER-2 in breast cancer. Med. Hypotheses 65, 546-551 (2005)
57. T. Tsuji, F. Okada, K. Yamaguchi, T. Nakamura, Molecular cloning of the large subunit of transforming growth factor type beta masking protein and expression of the mRNA in various rat tissues. Proc. Natl Acad. Sci. U.S.A. 87, 8835-8839 (1990)
58. Y. Wang, W. Zhu, D.E. Levy, Nuclear and cytoplasmic mRNA quantification by SYBR green based real-time RT-PCR. Methods 39, 356-362 (2006)
59. B.J. Warner, S.W. Blain, J. Seoane, J. Massague, Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway. Mol. Cell. Biol. 19, 5913-5922 (1999)
60. L. Ye, S.M. Bokobza, W.G. Jiang, Bone morphogenetic proteins in development and progression of breast cancer and therapeutic potential (review). Int. J. Mol. Med. 24, 591-597 (2009)
61. W. Yin, E. Smiley, J. Germiller, R.P. Mecham, J.B. Florer, R.J. Wenstrup, J. Bonadio, Isolation of a novel latent transforming growth factor-beta binding protein gene (LTBP-3). J. Biol. Chem. 270, 10147-10160 (1995)
62. K. Yoshinaga, H. Obata, V. Jurukovski, R. Mazzieri, Y. Chen, L. Zilberberg, D. Huso, J. Melamed, P. Prijatelj, V. Todorovic, B. Dabovic, D.B. Rifkin, Perturbation of transforming growth factor (TGF)-beta1 association with latent TGF-beta binding protein yields inflammation and tumors. Proc. Natl Acad. Sci. U.S.A. 105, 18758-18763 (2008)